BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17661718)

  • 1. Future of molecular profiling of human hepatocellular carcinoma.
    Roessler S; Budhu A; Wang XW
    Future Oncol; 2007 Aug; 3(4):429-39. PubMed ID: 17661718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic profiling of human hepatocellular carcinoma.
    Lee JS; Thorgeirsson SS
    Semin Liver Dis; 2005; 25(2):125-32. PubMed ID: 15918141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.
    Lemmer ER; Friedman SL; Llovet JM
    Semin Liver Dis; 2006 Nov; 26(4):373-84. PubMed ID: 17051451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
    Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
    Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional genomics of hepatocellular carcinoma.
    Thorgeirsson SS; Lee JS; Grisham JW
    Hepatology; 2006 Feb; 43(2 Suppl 1):S145-50. PubMed ID: 16447291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of hepatocellular carcinoma.
    Aravalli RN; Steer CJ; Cressman EN
    Hepatology; 2008 Dec; 48(6):2047-63. PubMed ID: 19003900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatocellular carcinoma: expression profiles-based molecular interpretations and clinical applications.
    Hui KM
    Cancer Lett; 2009 Dec; 286(1):96-102. PubMed ID: 19095350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative genomic classification of human hepatocellular carcinoma].
    Kaposi-Novák P
    Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in tumor markers of human hepatocellular carcinoma.
    Yoon SK
    Intervirology; 2008; 51 Suppl 1():34-41. PubMed ID: 18544946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapies for hepatocellular carcinoma.
    Avila MA; Berasain C; Sangro B; Prieto J
    Oncogene; 2006 Jun; 25(27):3866-84. PubMed ID: 16799628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in prevention and diagnosis of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):425-33. PubMed ID: 19072390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profiling.
    Berzsenyi MD; Roberts SK; Beard MR
    Antivir Ther; 2006; 11(5):541-52. PubMed ID: 16964821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma.
    Wang SM; Ooi LL; Hui KM
    Clin Cancer Res; 2007 Nov; 13(21):6275-83. PubMed ID: 17975138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of multistage hepatocarcinogenesis.
    Sakamoto M; Effendi K; Masugi Y
    Jpn J Clin Oncol; 2010 Sep; 40(9):891-6. PubMed ID: 20603246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.